End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.53 CNY | +0.42% | +2.47% | -11.18% |
Apr. 25 | Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug | MT |
Sales 2024 * | 8.62B 1.19B | Sales 2025 * | 9.41B 1.3B | Capitalization | 9.13B 1.26B |
---|---|---|---|---|---|
Net income 2024 * | 467M 64.45M | Net income 2025 * | 636M 87.77M | EV / Sales 2024 * | 1.06 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
19.9
x | P/E ratio 2025 * |
14.4
x | Employees | 6,208 |
Yield 2024 * |
1.57% | Yield 2025 * |
2.1% | Free-Float | 58.61% |
1 day | +0.42% | ||
1 week | +2.47% | ||
Current month | +6.60% | ||
1 month | +5.77% | ||
3 months | -2.66% | ||
6 months | -8.89% | ||
Current year | -11.18% |
Managers | Title | Age | Since |
---|---|---|---|
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 06-05-31 |
Nan Xing Li
BRD | Director/Board Member | 38 | 15-06-10 |
Ke Qiu
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chun Bo Li
CHM | Chairman | 65 | 97-04-30 |
Nai Wei Chen
BRD | Director/Board Member | 67 | 18-06-14 |
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 06-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 31 M€ | +3.50% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.53 | +0.42% | 17,511,720 |
24-04-25 | 9.49 | +3.72% | 20,727,880 |
24-04-24 | 9.15 | 0.00% | 10,228,010 |
24-04-23 | 9.15 | -0.87% | 10,533,270 |
24-04-22 | 9.23 | -0.75% | 11,598,570 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.18% | 1.26B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 600216 Stock